Puma Biotechnology, Inc.

Release Summary

Puma Biotechnology expanded the fourth cohort of Phase II SUMMIT Trial in HER2 mutation-positive cancer patients. The expanded cohort includes patients with metastatic HER2 mutated cervical cancer.

Puma Biotechnology, Inc.